Tempus AI Targets Share of Cancer Therapy Business
WSJ reports Tempus AI positioning to enter Moderna and Merck cancer therapy business via Personalis.
The Wall Street Journal posted about its article on Tempus AI seeking a role supplying Moderna and Merck with services tied to their personalized cancer therapies. The piece names Personalis as central to the bet. It places the effort inside a larger push for cancer vaccines and the supporting tools that companies will need. The post contains no details on contracts, revenue, or results achieved so far.
Combined views
1 post, first seen 1d ago
Tempus AI Targets Share of Cancer Therapy Business
WSJ reports Tempus AI positioning to enter Moderna and Merck cancer therapy business via Personalis.
The Wall Street Journal posted about its article on Tempus AI seeking a role supplying Moderna and Merck with services tied to their personalized cancer therapies. The piece names Personalis as central to the bet. It places the effort inside a larger push for cancer vaccines and the supporting tools that companies will need. The post contains no details on contracts, revenue, or results achieved so far.